Effect of FCGR2A and FCGR3A variants on CLL outcome. (Record no. 20043233)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02086 a2200661 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515234635.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201012s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1528-0020 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1182/blood-2010-03-272765 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Dornan, David |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20101221 |
| 245 00 - TITLE STATEMENT | |
| Title | Effect of FCGR2A and FCGR3A variants on CLL outcome. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Blood |
| Date of publication, distribution, etc. | Nov 2010 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 4212-22 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
| General subdivision | pharmacokinetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclophosphamide |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Lymphocytic, Chronic, B-Cell |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polymorphism, Single Nucleotide |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, IgG |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rituximab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vidarabine |
| General subdivision | analogs & derivatives |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spleiss, Olivia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yeh, Ru-Fang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Duchateau-Nguyen, Guillemette |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dufour, Annika |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhi, Jianguo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Robak, Tadeusz |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moiseev, Sergey I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dmoszynska, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Solal-Celigny, Philippe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Warzocha, Krzysztof |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Loscertales, Javier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Catalano, John |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Afanasiev, Boris V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Larratt, Loree |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rossiev, Viktor A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bence-Bruckler, Isabelle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Geisler, Christian H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Montillo, Marco |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wenger, Michael K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Weisser, Martin |
| 773 0# - HOST ITEM ENTRY | |
| Title | Blood |
| Related parts | vol. 116 |
| -- | no. 20 |
| -- | p. 4212-22 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1182/blood-2010-03-272765">https://doi.org/10.1182/blood-2010-03-272765</a> |
| Public note | Available from publisher's website |
No items available.